跳至主要内容
临床试验/DRKS00031974
DRKS00031974招募中Unknown

Effect of transcutaneous aurical vagal nerve stimulation (taVNS) on fatigue in patients with long covid. - CoviVa

niversitätsklinik Knappschaftskrankenhaus Bochum0 个研究点目标入组 45 人开始时间: 2023年5月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Z.n. completed Covid infection within the last 18 months
  • - Fatigue persisting for = 3 months with a score =4 on the FSS fatigue scale
  • - Age >18
  • - No depression or depression that has been treated stably for 4 weeks

排除标准

  • - Serious psychiatric illness such as schizophrenia
  • - Acute corona infection
  • - >8 items on the NGASR suicide questionnaire
  • - Vagus nerve stimulation or condition vagotomy
  • - Relevant cardiac disease: bradycardiac cardiac arrhythmia (e.g. sick sinus syndrome), cardiac insufficiency, status post. Heart attack
  • - Active implant such as cardiac pacemaker, defibrillator, neurostimulator, cochlear implant or drug delivery device and ventricular shunt.
  • - Inability to understand the study
  • - Progressive neurological disease (e.g. Parkinson's, MS, epilepsy)
  • - pregnancy
  • - Other acute illness associated with fatigue (e.g. cancer, chemotherapy, autoimmune diseases)
  • - Polyneuropathy
  • - Presence of a skin condition such as infection, psoriasis or eczema in the treatment area.
  • - Presence of any anatomical abnormality that prevents the successful insertion of the ear electrode.
  • - Presence of any serious medical condition that prevents successful participation in the study.

研究者

发起方
niversitätsklinik Knappschaftskrankenhaus Bochum

相似试验